Connect with us


Rwanda Joins African Nations in Issuing Recall of J&J Children’s Cough Syrup



Rwanda joins other African countries in recalling J&J children's cough syrup, ET HealthWorld

Kigali: Rwanda’s drug regulator has recalled a batch of Johnson & Johnson children’s cough syrup as a precautionary measure after its Nigerian counterpart said laboratory tests found high levels of toxicity. Rwanda joins Nigeria, Kenya, and South Africa in recalling the same batch of the syrup, which is used to treat coughs, hay fever, and other allergic reactions in children.

The batch in question was manufactured by J&J in South Africa in May 2021, but Kenvue now owns the Benylin Paediatric syrup brand after a spin-off from J&J last year. The Rwanda Food and Drugs Authority stated in a press release dated April 12 that while there have been no adverse events reported in their safety database, they are issuing the recall as a precautionary measure.

Laboratory tests conducted by Nigeria’s health regulator revealed a high level of diethylene glycol in the syrup. This chemical has been linked to the deaths of numerous children in Gambia, Uzbekistan, and Cameroon since 2022, marking one of the world’s most significant instances of poisoning from oral medication.

Kenvue, the current owner of the Benylin Paediatric brand, indicated that they are conducting their own assessment and working closely with health authorities to determine the appropriate course of action. The company is taking the matter seriously and prioritizing the safety of consumers. This development serves as a reminder of the importance of stringent quality control measures in the pharmaceutical industry to prevent harmful substances from reaching the market.

Click to comment

You must be logged in to post a comment Login

Leave a Reply